Sign in

CIK 0001894562 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. 4 Gift See Remarks gave 12,500 shares (gift)
  2. 4/A Gift 10% owner gave 1,000,000 shares (gift)
  3. 4 Gift 10% owner gave 1,000,000 shares (gift)
  4. 4 Planned sale 10% owner sold 56,408 shares at an average $15.03 ($847,744)
  5. 4 Planned sale 10% owner sold 73,191 shares at an average $14.93 ($1,092,435)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale 10% owner sold 57,060 shares at an average $15.00 ($855,787)
  13. 4 Planned sale 10% owner sold 31,703 shares at an average $14.73 ($467,135)
  14. 4 Planned sale 10% owner sold 20,000 shares at an average $16.63 ($332,557)
  15. 4 Planned sale 10% owner sold 52,409 shares at an average $16.88 ($884,777)
  16. 4 Planned sale 10% owner sold 61,856 shares at an average $14.17 ($876,198)
  17. 4 Planned sale 10% owner sold 29,407 shares at an average $13.70 ($402,844)
  18. 4 Planned sale 10% owner sold 31,061 shares at an average $13.45 ($417,893)
  19. 4 Planned sale 10% owner sold 131,861 shares at an average $14.33 ($1,889,739)
  20. 4 Planned sale 10% owner sold 90,310 shares at an average $13.62 ($1,230,338)

Page 5 of 7 · 140 filings